Menu
Contact Us
Subscribe
Menu

Medicines Law & Policy releases analysis, tools, and data to influence policy and practices to improve access to medicines.

Pandemic Accord

ML&P has been closely following the process towards the creation of a new international instrument to better prevent, prepare...

Our research

ML&P delves into complex public health issues, seeking to make the legal implications of international legislation clearer, and to...

Blog

Medicines Law & Policy periodically will post timely analysis and insight into current events related to intellectual property and...

TRIPS Flexibilities Database

The TRIPS Flexibilities Database contains instances when authorities have invoked, planned to invoke, or have been asked to invoke...

Latest Blog Posts from Medicines Law & Policy

Transfer of Technology: New definition and stronger language needed

Medicines Law & Policy -
Statement by Medicines Law & Policy on Article 11, Technology Transfer Intergovernmental Negotiating Body on a Pandemic Accord (INB), Session 12 Delivered at the WHO on...

Getting to a meaningful agreement: ML&P’s opening statement to the 12th round of pandemic accord negotiations

Medicines Law & Policy -
Thank you for giving us the opportunity to address the opening session of the INB12. We would like to make the following points: A pandemic agreement...

UN “Pact for the Future” intellectual property actions need revision to ensure innovation and access to health products for all

Ellen 't Hoen -
UPDATE: From 22-23 September 2024, the Summit of the Future took place and adopted the Pact for the Future. The intellectual property paragraph of...

World Trade Organization Members Embark on Review of the TRIPS Agreement

Ellen 't Hoen -
The World Trade Organization (WTO) Trade-Related Aspects of Intellectual Property Rights (TRIPS) Council will meet on 10-11 July. On the agenda is the review...

MSF’s Access Campaign is an invaluable actor in global health; shutting it down is short-sighted.

Medicines Law & Policy -
On 20 June, STAT News reported that Médecins Sans Frontières (MSF) is closing down their Access Campaign, effective as of 31 December 2024. It...

The new IP strategy of war-torn Ukraine should prioritise public health and national security

Olga Gurgula -
Russia’s full-scale assault on Ukraine continues for the third year. The Russian occupation forces have already killed tens of thousands of civilians, including children. They have...

Continuing to ignore the problem of the know-how gap won’t make it go away.

Christopher Garrison -
The Covid-19 pandemic was a wake-up call for a variety of issues in access to medicines, one of which was finding a solution to...

Pharmaceutical Accountability Foundation meets AbbVie in court, looking to advance its pricing case

Kaitlin Mara -
“The value of a human life is infinite, but unfortunately our healthcare budget is not,” said former Dutch Health Minister Bruno Bruins, quoted by...

Pressure from European countries related to the use of TRIPS Flexibilities 

Medicines Law & Policy -
The draft text of the World Health Organization pandemic accord reaffirms countries' rights to use to the full the flexibilities contained in the World...

The last mile: A few suggestions for the WHO Pandemic Agreement’s last two weeks of talks 

Ellen 't Hoen -
This technical briefing note is also available as a PDF here. On 16 April, the Bureau of the Intergovernmental Negotiating Body (INB) to draft and...
See all blogs

Twitter


Research Highlights

Current drafts of the WHO Pandemic Accord lack a provision for access to knowhow/trade secrets. We drafted one.

Medicines Law & Policy

15 July 2022

Seven recommendations for sharing IP, know-how and technology – report of Global Expert Group on the Pandemic Treaty

BMJ Global Health

15 July 2022

Scaling-up Vaccine Production Capacity: Legal Challenges and Recommendations

The Independent Panel for Pandemic Preparedness and Response

May 2021

What is the ‘know-how gap’ problem and how might it impact scaling up production of Covid-19 related diagnostics, therapies and vaccines?

Medicines Law & Policy

May 2021

EU Review of Pharmaceutical Incentives: Recommendations for Change

Medicines Law & Policy

May 2021

Posts by Topic

Medicines Law & Policy

Medicines Law & Policy releases analysis, policy recommendations and tools to aid practitioners working on universal access to medicines. We strive to provide information that is as accurate as possible, and we welcome and encourage feedback. For comments or questions contact us at: office@medicineslawandpolicy.net.

Never miss a post! Sign up for ML&P's newsletter.

This work is licensed under Creative Commons. You are free to share, with attribution and without changes, for non-commercial purposes.